Ranked above it

Care Bare Rx
Tells you exactly what you're buying — but $199 is a starting point, not a rate.
#1 on our tirzepatide provider ranking, above Goldspan Health at #101.
Read the Care Bare Rx review →Provider review
Bills every 28 days while saying a month — thirteen charges a year.
Goldspan's hero prices semaglutide at $229 a month. The plan card underneath says "Billed every 28 days" and the order timeline says the plan renews every four weeks, which is thirteen charges across a year rather than twelve.
Reviewed by Marcus Webb
Transparency scorecard
2 of 4 disclosed openly
What Goldspan Health discloses about itself, read from its own pages — not estimated.
Pharmacy named & regulated
Not disclosed
Does not name a pharmacy or state a regulatory category anywhere on its own site.
State coverage published
Disclosed
Publishes which states it actually serves.
A real price is published
Disclosed
A real dollar figure is published on its own site, not estimated.
No hidden commitment trap
Not disclosed
The advertised price requires a prepay, auto-refill, or other commitment we found and named.
This review's stake, stated plainly — some of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
Ranked above it

Care Bare Rx
Tells you exactly what you're buying — but $199 is a starting point, not a rate.
#1 on our tirzepatide provider ranking, above Goldspan Health at #101.
Read the Care Bare Rx review →What this price covers
Medication
Included
Provider visits
Included
Shipping
Not confirmed
Lab work
Not confirmed
Coaching
Not confirmed
The catch — The cycle is 28 days, not a month. Goldspan's hero and its plan card both print "/month" while the plan card also says "Billed every 28 days" and the order timeline says the plan renews every four weeks. Thirteen charges a year at $229 is $2,977 rather than the $2,748 a monthly reading implies, and $3,887 rather than $3,588 on tirzepatide.
See plans at Goldspan HealthPrices read from Goldspan Health's own site · September 2026
What they advertise
$229 for compounded semaglutide with B12 and $299 for tirzepatide, each shown as "From $229 /month" and "From $299 /month" in the hero, then as a flat $229 and $299 on the single plan card. Sublingual microdoses run $149 and $199, and full-dose sublinguals $199 and $299.
What you actually pay
$229 per 28 days for compounded semaglutide and $299 per 28 days for tirzepatide — the only plan on offer, so the "from" figure and the rate are the same number. Over a year that is thirteen charges rather than twelve.
Money you will meet later
Goldspan Health sells a longevity catalog across eleven categories — GLP-1s, sermorelin, NAD+, glutathione, testosterone, hormone therapy — and takes payment through a storefront operated by Altro Health. Compounded semaglutide is $229 and tirzepatide $299, each on a single plan with no prepay tier, no introductory rate and a clear list of what is inside. Two things are worth knowing before you buy. The plan bills every 28 days rather than monthly, so a year is thirteen charges and not twelve. And Goldspan Health itself publishes no legal entity, no address and no governing law anywhere on its site — the only company you can identify from the paperwork is the platform it sells through.
Goldspan Health appears on our tirzepatide provider ranking, our semaglutide provider ranking and our combined weight loss injections ranking. Nothing on this page is a performance claim.
Tap any compound to read our plain-English guide — what the evidence shows, how it is dosed, and what it costs elsewhere.
Goldspan Health does not name the pharmacy that fills your prescription.
No pharmacy is named. Goldspan states the class and stops there: its Terms say all therapies are dispensed by a pharmacy licensed under section 503A or 503B, and its storefront footer repeats it, but no facility is identified on either site. Three clinicians are named by surname only — a medical director and two clinical advisors, all described as part of an independent medical group rather than employees — with no first names and no NPI. The LegitScript seal shown on the storefront certifies that platform's domain rather than Goldspan's own.
A 503A pharmacy compounds for one named patient; a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Compounded peptides are not FDA-approved.
Its homepage says the service is available in 50 states and the storefront footer says all 50 plus Washington, D.C. Its own Terms qualify that: some therapies are unavailable in certain states or based on medical history. Which therapies, and which states, is not published.
The part they would rather you skipped
Goldspan Health sells prescription drugs without telling you who Goldspan Health is. There is no LLC, no Inc., no street address, no state of incorporation and no governing law anywhere on its site — the Terms open by describing "Goldspan Health" as a platform and never name a company behind it. The only identifiable entity in the transaction is Lyv Health, Inc., trading as Altro Health in New York, which runs the storefront that takes the money and whose Terms bring Delaware law with them. The certification badge follows the same pattern: the LegitScript seal a buyer sees is issued to the storefront's domain, not to Goldspan's. Alongside that, the price is quietly a 28-day price sold in the language of a month, and the tirzepatide microdose page describes what is in the box as compounded sublingual semaglutide.
None of this is unique to Goldspan Health — the whole category shares it.
The providers we rank on our tirzepatide provider ranking — the most specific board Goldspan Health sits on — in the order that board ranks them. It sells into other categories too; see the boards listed above under the bottom line.





139 more providers rank on our tirzepatide provider ranking — see the full ranking. Every provider we review →
A provider comparison is half the decision. The other half is whether the compound does anything for you at all. The evidence below is where that gets settled.
Ready to get started?
Prices and plans in this category change often — check Goldspan Health's current pricing before you decide. Ours was read from their own site in September 2026.
Facts on this page reflect Goldspan Health's own public disclosures when we last checked them, in September 2026. Prices and terms change without notice — confirm on Goldspan Health's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved. See our disclosure and editorial policy.
Goldspan Health
2 compounds from $229 / 28 days (about $249/mo)